Sign In
7 Apr 2015 14:59
Post-stabilisation announcement (no stabilisation)
07 April 2015
Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.
Teva Pharmaceutical Finance Netherland II BV
Post Stabilisation Notice
Barclays Bank PLC (contact: Karan Shah) hereby gives notice that no stabilisation (within the meaning of the rules of the Financial Services Authority) was undertaken by the Stabilising Manager(s) named below in relation to the offer of the following securities.
Issuer: | Teva Pharmaceutical Finance Netherland II BV |
Guarantor (if any): | Teva Pharmaceutical Industries Limited |
Aggregate nominal amount: | 8 Year - EUR 1.3Bn 12 Year - EUR 700m |
Description: | 8 Year - 1.25% Due 2023 - XS1211040917 12 Year - 1.875% Due 2027 - XS1211044075 |
Offer price: | 8 Year - 99.059 12 Year - 99.501 |
Stabilisation Manager: | Barclays Bank PLC |
This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.
This announcement is not an offer of securities for sale into the United States. The securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There has not been and will not be a public offer of the securities in the United States.
Follow the stocks
